Korea Institute of Science and Technology

Young Sook Yoo

Byung Hwa Jung

Min-Jung Kang

Min Cheol Park

Hyunjung Lee

Eun Joo Song

Thanh Binh Nguyen

Eunmi Ban

Eunice EunKyeong Kim

Provided are a method of screening for novel therapeutic targets to develop therapeutic agents for colon cancer, and prognostic biomarkers for colon cancer treatment which are screened using the same.

Method of screening for novel therapeutic targets to develop therapeutic agents for colon cancer and prognostic biomarkers for colon cancer treatment screened using the same

Rheumatoid arthritis is efficiently diagnosed with improved patient's convenience using a rheumatoid arthritis diagnosis composition and a kit, each including cyclic citrullinated peptide (CCP), a rheumatoid arthritis diagnosis method using the CCP, the rheumatoid arthritis diagnosis composition, or the kit, a method of obtaining information for rheumatoid arthritis diagnosis, and a method of screening a novel diagnostic marker for rheumatoid arthritis.

Cyclic citrullinated peptide, rheumatoid arthritis diagnosis composition including the same, rheumatoid arthritis diagnosis method using the peptide or the composition, and method of screening diagnostic marker for rheumatoid arthritis

Provided are a method of analyzing ubiquitin-proteasome activity with respect to a target polypeptide and a method of screening a ubiquitin-proteasome inhibitor. According to the provided methods, the pattern of lysis of a target polypeptide by a ubiquitin-proteasome in target cells may be quantitatively analyzed in a rapid and highly sensitive way, a ubiquitin-proteasome inhibitor may be screened in a rapid and highly sensitive way, and an anticancer agent and the activity thereof may be rapidly screened.

Rapid method to analyze ubiquitin-proteasome activity and to screen for ubiquitin-proteasome inhibitor

Growing community of inventors

Seoul, South Korea

Young Sook Yoo